A Randomized Controlled Study for Yunping Recipe in the Treatment of Vestibular Migraine with Syndrome of Hyperactivity of Liver Yang

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037202

Enrollment

Unknown

Registered

2020-08-27

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular migraine

Interventions

Experimental group:Yunping recipe

Control group:Yunping recipe placebo

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for vestibular migraine; 2. Conforming to the dialectial theory of traditional Chinese medicine,hyperactivity of liver-yang of vertigo; 3. Aged from 18 to 80 years; 4. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Organic diseases related to the vestibular system; 2. Patients with contraindications to flunarizine; 3. Patients with severe heart, brain, liver and kidney hematopoietic system endocrine system diseases. 4. Women who are breastfeeding or preparing to conceive during pregnancy; 5. Allergies, such as those with a history of allergies to two or more drugs or foods and those who are known to be allergic to the ingredients of this drug.

Design outcomes

Primary

Measure	Time frame
Dizziness Handicap Inventory;Blood routine, liver and kidney function, electrocardiogram;	—

Countries

China

Contacts

Public ContactZhang Lingling

Shanghai Municipal Hospital of Traditional Chinese Medicine

yinghytz@126.com+86 18116013380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026